AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $76,000 | +100.0% | 5,030 | 0.0% | 0.00% | – |
| Q2 2022 | $38,000 | -17.4% | 5,030 | 0.0% | 0.00% | – |
| Q1 2022 | $46,000 | +31.4% | 5,030 | 0.0% | 0.00% | – |
| Q4 2021 | $35,000 | -38.6% | 5,030 | 0.0% | 0.00% | – |
| Q3 2021 | $57,000 | -29.6% | 5,030 | 0.0% | 0.00% | – |
| Q2 2021 | $81,000 | -10.0% | 5,030 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $90,000 | +32.4% | 5,030 | 0.0% | 0.00% | – |
| Q4 2020 | $68,000 | +15.3% | 5,030 | 0.0% | 0.00% | – |
| Q3 2020 | $59,000 | -20.3% | 5,030 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $74,000 | +51.0% | 5,030 | +39.7% | 0.00% | – |
| Q1 2020 | $49,000 | -9.3% | 3,601 | +60.0% | 0.00% | – |
| Q4 2019 | $54,000 | +25.6% | 2,250 | 0.0% | 0.00% | – |
| Q3 2019 | $43,000 | -34.8% | 2,250 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $66,000 | -38.3% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $107,000 | +8.1% | 2,250 | -18.3% | 0.00% | 0.0% |
| Q4 2018 | $99,000 | -28.3% | 2,753 | +23.0% | 0.00% | 0.0% |
| Q3 2018 | $138,000 | -8.6% | 2,238 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $151,000 | +65.9% | 2,238 | +33.1% | 0.00% | 0.0% |
| Q1 2018 | $91,000 | -9.0% | 1,681 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $100,000 | +53.8% | 1,681 | +25.4% | 0.00% | 0.0% |
| Q3 2017 | $65,000 | -7.1% | 1,341 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $70,000 | +29.6% | 1,341 | +13.1% | 0.00% | 0.0% |
| Q1 2017 | $54,000 | +20.0% | 1,186 | 0.0% | 0.00% | – |
| Q4 2016 | $45,000 | +12.5% | 1,186 | +12.1% | 0.00% | – |
| Q3 2016 | $40,000 | – | 1,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|